Based on the Oscar Health Inc stock forecast from 5 analysts, the average analyst target price for Oscar Health Inc is USD 23.81 over the next 12 months. Oscar Health Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Oscar Health Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Oscar Health Inc’s stock price was USD 15.98. Oscar Health Inc’s stock price has changed by +7.46% over the past week, -0.31% over the past month and +88.00% over the last year.
No recent analyst target price found for Oscar Health Inc
No recent average analyst rating found for Oscar Health Inc
Company Overview Oscar Health Inc
Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York. Read Less
Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also p...Read More
Frequently Asked Questions About Oscar Health Inc (OSCR) Stock
Based on ratings from 5 analysts Oscar Health Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, 1 sell and 2 hold ratings.
Unfortunately we do not have enough data on OSCR's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for OSCR is USD 23.81 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 13.5.
Unfortunately we do not have enough data on OSCR's stock to indicate if its overvalued.
The last closing price of OSCR's stock was USD 15.98.
The most recent market capitalization for OSCR is USD 4.45B.
Based on targets from 5 analysts, the average taret price for OSCR is projected at USD 23.81 over the next 12 months.
This means that OSCR's stock price may go up by +49.01% over the next 12 months.
We can't find any ETFs which contains Oscar Health Inc's stock.
As per our most recent records Oscar Health Inc has 2,400 Employees.
Oscar Health Inc's registered address is 75 Varick Street, New York, NY, United States, 10013.
You can get more information about it from Oscar Health Inc's website at https://www.hioscar.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Oscar Health Inc (OSCR) Stock
Based on ratings from 5 analysts Oscar Health Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, 1 sell and 2 hold ratings.
Unfortunately we do not have enough data on OSCR's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for OSCR is USD 23.81 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 13.5.
Unfortunately we do not have enough data on OSCR's stock to indicate if its overvalued.
The last closing price of OSCR's stock was USD 15.98.
The most recent market capitalization for OSCR is USD 4.45B.
Based on targets from 5 analysts, the average taret price for OSCR is projected at USD 23.81 over the next 12 months.
This means that OSCR's stock price may go up by +49.01% over the next 12 months.
We can't find any ETFs which contains Oscar Health Inc's stock.
As per our most recent records Oscar Health Inc has 2,400 Employees.
Oscar Health Inc's registered address is 75 Varick Street, New York, NY, United States, 10013.
You can get more information about it from Oscar Health Inc's website at https://www.hioscar.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for OSCR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
